ribavirin has been researched along with guanosine monophosphate in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Borek, E; Fujitaki, J; Goswami, BB; Sharma, OK; Smith, RA | 1 |
| Nagai, M; Nakamura, H; Natsumeda, Y; Szekeres, T; Weber, G | 1 |
| Balzarini, J; De Clercq, E; Lee, CK; Schols, D | 1 |
| Faderan, MA; Jayaram, HN; Lui, MS; Pillwein, K; Weber, G | 1 |
| Natsumeda, Y; Weber, G; Yamada, Y; Yamaji, Y | 1 |
| Herrmann, B; Kaiser, WA; Keppler, DO | 1 |
| Alling, DW; Knight, V; Longoria, RM; Moore, RV; Wilson, SZ | 1 |
| Chiba, P; Gharehbaghi, K; Lhotka, C; Pillwein, K; Ressmann, G; Schuchter, K; Szalay, SM; Szekeres, T | 1 |
| Yamaoka, T | 1 |
| Weber, G | 1 |
| Bozsik, A; Keszei, M; Kökény, S; Oláh, E; Papp, J | 1 |
| Box, T; Chen, J; Dejesus, E; Dubuc-Patrick, G; Godofsky, E; Kwo, P; Lalezari, J; Lawrence, S; Mayers, D; McCarville, J; Mehra, P; Nguyen, T; O'Riordan, W; Pietropaolo, K; Poordad, F; Sullivan-Bólyai, J; Zhou, XJ | 1 |
| Bilello, JP; Chapron, C; Gillum, JM; La Colla, M; Lallos, LB; McCarville, JF; Pierra, C; Seifer, M; Serra, I; Standring, DN | 1 |
| Asahina, Y; Doi, A; Hikita, H; Kai, Y; Kato, T; Kodama, T; Murayama, A; Nakabori, T; Nitta, S; Saito, Y; Sakamori, R; Suemizu, H; Tahata, Y; Takehara, T; Tatsumi, T; Yamada, R | 1 |
| Elfiky, AA | 1 |
2 review(s) available for ribavirin and guanosine monophosphate
| Article | Year |
|---|---|
[IMP dehydrogenase].
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Feedback, Physiological; Genes, Dominant; Guanosine Monophosphate; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Mycophenolic Acid; Pigment Epithelium of Eye; Protein Conformation; Protein Structure, Tertiary; Purine Nucleotides; Retinal Degeneration; Ribavirin; Ribonucleosides | 2003 |
Modulation of cancer pathways by inhibitors of guanylate metabolism.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Guanosine Monophosphate; Humans; IMP Dehydrogenase; Neoplasms; Ribavirin; Signal Transduction | 2006 |
1 trial(s) available for ribavirin and guanosine monophosphate
| Article | Year |
|---|---|
IDX184 in combination with pegylated interferon-α2a and ribavirin for 2 weeks in treatment-naive patients with chronic hepatitis C.
Topics: Adult; Antiviral Agents; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Guanosine Monophosphate; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Genetic; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load | 2013 |
12 other study(ies) available for ribavirin and guanosine monophosphate
| Article | Year |
|---|---|
The broad spectrum antiviral agent ribavirin inhibits capping of mRNA.
Topics: Guanosine Monophosphate; Guanosine Triphosphate; Kinetics; L Cells; Nucleotidyltransferases; Ribavirin; Ribonucleosides; RNA, Messenger; Uridine Monophosphate | 1979 |
Regulation of GTP biosynthesis.
Topics: Animals; Cell Differentiation; Cell Division; Colonic Neoplasms; Evaluation Studies as Topic; GMP Reductase; Guanosine Monophosphate; Guanosine Triphosphate; Humans; Hypoxanthine; Hypoxanthines; IMP Dehydrogenase; Inosine Monophosphate; Leukemia, Promyelocytic, Acute; Liver Neoplasms, Experimental; NADH, NADPH Oxidoreductases; Ribavirin; Tumor Cells, Cultured | 1992 |
1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymph
Topics: Antiviral Agents; Cells, Cultured; Didanosine; Drug Synergism; Guanosine Diphosphate; Guanosine Monophosphate; Guanosine Triphosphate; HIV-1; Humans; Inosine Monophosphate; Kinetics; Lymphocytes; Ribavirin; Ribonucleosides | 1991 |
Mechanism of resistance to tiazofurin in hepatoma 3924A.
Topics: Adenosine Monophosphate; Animals; Antineoplastic Agents; Biological Transport; Cell Cycle; Cell Line; Drug Resistance; Guanine; Guanosine Monophosphate; IMP Dehydrogenase; Inosine Monophosphate; Liver Neoplasms, Experimental; Nicotinamide-Nucleotide Adenylyltransferase; Rats; Ribavirin; Ribonucleosides | 1986 |
Synergistic cytotoxic effect of tiazofurin and ribavirin in hepatoma cells.
Topics: Animals; Cell Line; Cell Survival; Drug Synergism; Guanosine Monophosphate; IMP Dehydrogenase; Liver Neoplasms, Experimental; Organoselenium Compounds; Purines; Rats; Ribavirin; Ribonucleosides; Selenium | 1988 |
Selective guanosine phosphate deficiency in hepatoma cells induced by inhibitors of IMP dehydrogenase.
Topics: Animals; Cell Division; Cell Line; Female; Guanine Nucleotides; Guanosine Diphosphate; Guanosine Monophosphate; Guanosine Triphosphate; IMP Dehydrogenase; Ketone Oxidoreductases; Kinetics; Liver Neoplasms, Experimental; Mice; Mycophenolic Acid; Ribavirin; Ribonucleosides; Uridine Monophosphate | 1980 |
Lack of interference of guanosine with ribavirin aerosol treatment of influenza A infection in mice.
Topics: Aerosols; Animals; Cells, Cultured; Female; Guanosine; Guanosine Monophosphate; Influenza A virus; Injections, Intraperitoneal; Mice; Mice, Inbred Strains; Orthomyxoviridae Infections; Ribavirin; Ribonucleosides | 1981 |
Synergistic action of tiazofurin with hypoxanthine and allopurinol in human neuroectodermal tumor cell lines.
Topics: Allopurinol; Cell Division; Dose-Response Relationship, Drug; Drug Synergism; Guanosine Monophosphate; Humans; Hypoxanthine; Hypoxanthines; IMP Dehydrogenase; Neuroblastoma; Ribavirin; Tumor Cells, Cultured | 1993 |
Metabolic regulation and chemotherapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Guanosine Monophosphate; Homeostasis; Humans; Neoplasms; Ribavirin | 2006 |
In vitro activity and resistance profile of samatasvir, a novel NS5A replication inhibitor of hepatitis C virus.
Topics: Antiviral Agents; Benzimidazoles; Carbamates; Cell Line; Dose-Response Relationship, Drug; Drug Resistance, Viral; Drug Synergism; Gene Expression Regulation, Viral; Genotype; Guanosine Monophosphate; Hep G2 Cells; Hepacivirus; Humans; Interferon-alpha; Mutation; Replicon; Ribavirin; Viral Nonstructural Proteins; Virus Replication | 2014 |
Combinations of two drugs among NS3/4A inhibitors, NS5B inhibitors and non-selective antiviral agents are effective for hepatitis C virus with NS5A-P32 deletion in humanized-liver mice.
Topics: Aged; Animals; Antiviral Agents; Benzimidazoles; Benzofurans; Carbamates; Cell Line; Chimera; Drug Resistance, Viral; Drug Therapy, Combination; Fluorenes; Guanosine Monophosphate; Hepacivirus; Hepatitis C; Hepatocytes; Heterocyclic Compounds, 4 or More Rings; Humans; Imidazoles; Interferon alpha-2; Interferon-alpha; Male; Mice; Middle Aged; Polyethylene Glycols; Pyrrolidines; Recombinant Proteins; Ribavirin; Sequence Deletion; Serine Proteases; Simeprevir; Valine; Viral Nonstructural Proteins | 2019 |
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.
Topics: Adenosine Monophosphate; Alanine; Alphacoronavirus; Amino Acid Sequence; Antiviral Agents; Betacoronavirus; Catalytic Domain; Computational Biology; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Guanosine Monophosphate; Guanosine Triphosphate; Humans; Molecular Docking Simulation; Pneumonia, Viral; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Ribavirin; RNA-Dependent RNA Polymerase; SARS-CoV-2; Sequence Alignment; Sequence Homology, Amino Acid; Sofosbuvir; Thermodynamics; Uridine Triphosphate; Viral Proteins | 2020 |